Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults

Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71–80 years of age. Low antibody levels in 31.5% of this population indicates that addr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanz-Muñoz, Iván, Sánchez-dePrada, Laura, Sánchez-Martínez, Javier, Rojo-Rello, Silvia, Domínguez-Gil, Marta, Hernán-García, Cristina, Fernández-Espinilla, Virginia, de Lejarazu-Leonardo, Raúl Ortiz, Castrodeza-Sanz, Javier, Eiros, José María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973709/
https://www.ncbi.nlm.nih.gov/pubmed/36732061
http://dx.doi.org/10.3201/eid2903.221231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973709/
https://www.ncbi.nlm.nih.gov/pubmed/36732061
http://dx.doi.org/10.3201/eid2903.221231

Ejemplares similares